GlassScriptPhysician profile
Jamie Hanosh
NPI 1497471197
$3,343.44
in general payments reported to CMS, 2019-2025
44 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.41 · 2023: $792 · 2024: $916 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,266.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.24 | 2023-2025 | |
| Edwards Lifesciences Corporation | $292.44 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $267.44 | 2024-2025 | Airsupra |
| Pfizer INC. | $265.81 | 2023-2025 | |
| Alkermes, INC. | $221.50 | 2023-2025 | Aristada, Lybalvi, Vivitrol |
| Novo Nordisk INC | $133.17 | 2024-2025 | Wegovy |
| Neurocrine Biosciences, INC. | $115.91 | 2022-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $112.72 | 2022-2025 | Caplyta |
| Lilly USA, LLC | $83.40 | 2023-2025 | Mounjaro, Zepbound |
| Tempus Ai, INC | $82.88 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $80.44 | 2022-2025 | Rexulti |
| Lundbeck LLC | $72.58 | 2023-2024 | Brintellix, Rexulti |
| Aimmune Therapeutics, INC. | $66.37 | 2024-2025 | Zenpep |
| Amgen INC. | $65.61 | 2023-2025 | Repatha, Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $63.67 | 2023-2024 | Trintellix |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $50.78 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $49.26 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $45.94 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Qol Medical, LLC | $37.45 | 2023 | Sucraid |
| Paratek Pharmaceuticals, INC. | $36.04 | 2024-2025 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $34.82 | 2025 | |
| Axsome Therapeutics, INC. | $33.66 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $32.92 | 2023-2024 | Airduo Digihaler, Austedo Xr |
| Boston Scientific Corporation | $32.51 | 2025 | Wavewriter Alpha Prime 16 |
| Exeltis, USA INC. | $28.26 | 2023 | Slynd |
| Idorsia Pharmaceuticals US INC | $26.57 | 2023-2024 | Quviviq |
| Janssen Pharmaceuticals, INC | $26.23 | 2024 | Spravato |
| Sonex Health, INC. | $26.16 | 2025 | Sx-One Microknife |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $26.13 | 2025 | |
| Brainsway USA INC | $24.25 | 2023 | |
| Bausch Health US, LLC | $23.93 | 2023 | Wellbutrin, Aplenzin |
| Inspire Medical Systems, INC. | $23.45 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $23.39 | 2025 | Arexvy, Shingrix |
| Lucid Diagnostics INC. | $19.52 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $19.04 | 2025 | Cobenfy |
| Xeris Pharmaceuticals, INC. | $18.92 | 2025 | Gvoke Hypopen |
| Cleerly, INC. | $18.39 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Eisai INC. | $15.60 | 2024 | |
| Phadia US INC. | $15.24 | 2025 | Immunocap |
| Biomerieux INC | $15.10 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.18 | 2024 | Xifaxan |
| Indivior INC. | $13.60 | 2023 | Perseris |
| Currax Pharmaceuticals LLC | $13.06 | 2022 | |
| Corium, LLC | $10.86 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Hanosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.